All Rankings

Top Biotech Startups in the UK 2026

Private biotechnology and genomics companies headquartered in the United Kingdom, ranked by disclosed lifetime funding.

Known total funding for 100 of 100 ranked companies: $12.9B.

Showing top 100 matching companies · Ranked by total funding raised

Use company data through the API.
Example request
curl "https://indexed.vc/api/v1/companies?industries=Biotech,Genomics&countries=United+Kingdom&operatingStatus=active&sort=total_funding_raised&order=desc&limit=100" -H "X-API-Key: YOUR_API_KEY"

The API can include out-of-scope company records; this core research list excludes them.

The API has no company type filter, so public companies can appear; this list counts private companies only.

The API cannot leave out companies whose latest round is a grant, private equity or debt financing; this list does.

Data from Indexed.vcUpdated

Methodology: up to 100 active companies matching this list's filters are ordered by disclosed total funding in USD. Companies whose latest round is one of: Grant, Private Equity, Debt Financing are excluded. Totals include recorded grants and other qualifying funding, not just equity. Open a company profile for its funding summary and available detail. How this data is built.

26
Ori Biotech

Ori Biotech builds the IRO platform that automates cell and gene therapy manufacturing and helps ...

London, United Kingdom11–50Biotech
Series BTotal funding$139.4MJan 2022
27
Enough

ENOUGH produces ABUNDA mycoprotein, a sustainable complete protein ingredient used in alternative...

Glasgow, United Kingdom51–200Biotech
Growth EquityTotal funding$138.0MAug 2023
28
Mission Therapeutics

Mission Therapeutics develops small molecules that inhibit USP30 to promote mitophagy and improve...

Cambridge, United Kingdom11–50Biotech, Healthcare
Venture RoundTotal funding$130.6MOct 2025
29
CHARM Therapeutics

AI-driven biotech developing next-generation menin inhibitors and small-molecule therapeutics for...

London, United Kingdom11–50Life Sciences, Biotech
Series BTotal funding$130.0MSep 2025
30
Microbiotica

Microbiome-based therapeutics and diagnostics

Cambridge, United Kingdom11–50Biotech, Healthcare
Series CTotal funding$116.2MOct 2026
31
Grey Wolf Therapeutics

Greywolf is a clinical-stage biotech advancing oral antigen-modulation therapies that control T c...

Oxford, United Kingdom11–50Biotech, Healthcare
Series BTotal funding$115.6MMay 2024
32
Paragraf

Paragraf is the first company to mass produce graphene-based electronic devices using standard se...

Cambridgeshire, United Kingdom51–200Biotech
Series CTotal funding$115.0MAug 2025
33
Healx

AI-enabled biotech using generative AI to discover and develop treatments for rare diseases, adva...

Cambridge, United Kingdom51–200Artificial Intelligence, Biotech
Series CTotal funding$114.5MAug 2024
34
Alchemab Therapeutics

Biotech company harnessing the immune systems of disease-resilient individuals to develop protect...

London, United Kingdom11–50Biotech
Extension RoundTotal funding$114.0MSep 2025
35
Myricx Bio

Biotech company focused on cell and gene therapy development.

London, United Kingdom1–10Biotech, Therapeutics
Venture RoundTotal funding$113.0MJul 2024
36
Trogenix

Trogenix builds precision genetic medicines that use Synthetic Super-Enhancers and AAV vectors to...

United Kingdom1–10Biotech
Series ATotal funding$107.5MOct 2025
37
Owlstone Medical

Cambridge UK biotech developing Breath Biopsy platform for early disease detection using volatile...

Cambridge, United Kingdom51–200Healthcare, Diagnostics
Series ETotal funding$107.0MJan 2025
38
ONI Bio

Super-resolution microscopy company offering imaging systems to accelerate biomedical discovery.

Oxford, United Kingdom51–200Biotech, Healthcare
Series BTotal funding$105.2MJan 2022
39
Sitryx Therapeutics

Sitryx Therapeutics develops novel oral therapies for patients with inflammatory disease, targeti...

Oxford, United Kingdom11–50Biotech, Healthcare
Series BTotal funding$99.0MJul 2022
40
Lightcast Discovery

Lightcast Discovery develops a flexible platform that enables precise interrogation of single-cel...

Cambridge, United Kingdom11–50Biotech, Healthcare
Venture RoundTotal funding$97.1MApr 2026
41
Mironid

Mironid® is developing novel small-molecule therapeutics that directly target the central signall...

Glasgow, United Kingdom11–50Biotech, Healthcare
Series BTotal funding$91.4MAug 2026
42
Akamis Bio

Akamis Bio is a UK clinical-stage biotech developing oncolytic immunotherapies targeting colorect...

London, United Kingdom11–50Biotech, Healthcare
Series ATotal funding$90.0MDec 2024
43
Maxion Therapeutics

Biotech developing antibody-based KnotBody therapeutics targeting ion channels and GPCRs to treat...

Cambridge, United Kingdom11–50Life Sciences, Biotech
Series ATotal funding$88.0MMar 2025
44
NRG Therapeutics

NRG Therapeutics is a neuroscience company developing novel medicines targeting mitochondrial dys...

Stevenage, United Kingdom11–50Biotech, Healthcare
Series BTotal funding$87.3MSep 2025
45
Immutrin

Immutrin is a biotechnology company developing next-generation antibody therapy to deplete system...

Cambridge, United Kingdom1–10Biotech
Venture RoundTotal funding$87.0MMar 2026
46
MOA

Agricultural biotech firm spun out of Oxford University developing a new generation of safe, effe...

Oxford, United Kingdom51–200Biotech, Climate Tech
Series CTotal funding$86.6MJul 2026
47
Mestag Therapeutics

Mestag Therapeutics develops fibroblast immunology-based therapies for cancer and inflammatory di...

London, United Kingdom11–50Biotech, Healthcare
Growth EquityTotal funding$85.0MMar 2026
48
Causaly

Causaly is an AI platform for life sciences research that enables scientists to rapidly discover ...

London, United Kingdom51–200Artificial Intelligence, Biotech
Series BTotal funding$78.0MJul 2023
49
Synthace

Antha biology software for automated lab experiment design

London, United Kingdom51–200Biotech, SaaS
Series DTotal funding$73.1MNov 2021
50
Constructive Bio

Constructive Bio expands the genetic code so cells can design, engineer, and manufacture proteins...

Cambridge, United Kingdom11–50Biotech
Series ATotal funding$73.0MSep 2024